PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28767356
OWN - NLM
STAT- MEDLINE
DA  - 20170802
DCOM- 20170808
LR  - 20170808
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 377
IP  - 5
DP  - 2017 Aug 03
TI  - Angiotensin II for the Treatment of Vasodilatory Shock - Promise and Caution.
PG  - 486-487
LID - 10.1056/NEJMe1706903 [doi]
FAU - Dellinger, R Phillip
AU  - Dellinger RP
AD  - From the Department of Medicine, Division of Critical Care Medicine, Cooper
      University Hospital and Cooper Medical School of Rowan University, Camden, NJ.
FAU - Trzeciak, Stephen
AU  - Trzeciak S
AD  - From the Department of Medicine, Division of Critical Care Medicine, Cooper
      University Hospital and Cooper Medical School of Rowan University, Camden, NJ.
LA  - eng
PT  - Editorial
PT  - Comment
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Vasoconstrictor Agents)
RN  - 11128-99-7 (Angiotensin II)
SB  - AIM
SB  - IM
CON - N Engl J Med. 2017 Aug 3;377(5):419-430. PMID: 28528561
MH  - *Angiotensin II
MH  - Humans
MH  - *Shock
MH  - Vasoconstrictor Agents
EDAT- 2017/08/03 06:00
MHDA- 2017/08/09 06:00
CRDT- 2017/08/03 06:00
AID - 10.1056/NEJMe1706903 [doi]
PST - ppublish
SO  - N Engl J Med. 2017 Aug 3;377(5):486-487. doi: 10.1056/NEJMe1706903.